MK Proteins Limited has announced a board meeting scheduled for February 13, 2026, to review and approve the company's quarterly financial performance. The meeting will focus on considering the unaudited financial results for the quarter ended December 31, 2025, as part of the company's regular financial disclosure obligations.

Board Meeting Details

The board meeting has been scheduled in accordance with Regulation 29 of the SEBI (LODR) Regulations, 2015. The company has formally notified both stock exchanges about the upcoming meeting through official communications.

Trading Window Restrictions

In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct for prevention of Insider Trading, MK Proteins has implemented trading restrictions. The trading window for the company's equity shares will remain closed until the financial results are declared.

The trading window will reopen 48 hours after the declaration of the unaudited financial results, allowing shareholders and investors to resume trading activities based on the disclosed financial information.

Regulatory Compliance

The announcement demonstrates MK Proteins' adherence to regulatory requirements and corporate governance standards. The company has fulfilled its disclosure obligations by informing both the Bombay Stock Exchange and National Stock Exchange of India about the scheduled board meeting.

The formal communication was signed by Neha Aggarwal, Company Secretary & Compliance Officer, ensuring proper authorization and compliance with regulatory protocols. This scheduled meeting represents part of the company's regular quarterly financial reporting cycle, maintaining transparency with stakeholders and regulatory authorities.

MK Proteins Limited, a company listed on the Bombay Stock Exchange and National Stock Exchange, has announced the appointment of Mr. Deepak Khetarpal as an Independent Director for a five-year term. The appointment, effective from August 23, 2025, was approved by shareholders at the company's 13th Annual General Meeting held on September 19, 2025.

Appointment Details

Mr. Khetarpal, who holds the Director Identification Number (DIN) 00732804, has been appointed in the category of Non-Executive Independent Director. His term will span five consecutive years, reflecting the company's commitment to long-term governance stability.

Professional Background

Deepak Khetarpal brings a wealth of experience to the board of MK Proteins Limited. He is a Qualified Cost and Works Accountant (CMA) from the Institute of Cost Accountants of India. His expertise spans several critical areas, including:

• Costing
• Finance
• Business Management
• Accounting
• Income Tax

Throughout his career, Mr. Khetarpal has built a reputation for his sharp analytical skills, strategic financial acumen, and result-oriented approach. These qualities have contributed significantly to the growth and success of organizations he has been associated with.

Independence and Compliance

In line with regulatory requirements, MK Proteins Limited has confirmed that Mr. Khetarpal is not related to any existing directors on the company's board. Additionally, he does not hold directorship in any other listed entities, which could potentially lead to conflicts of interest.

The company has also verified and declared that Mr. Khetarpal is not debarred from holding the office of director by virtue of any order from the Securities and Exchange Board of India (SEBI) or any other regulatory authority.

Shareholder Approval

The appointment of Mr. Deepak Khetarpal was put to vote at the Annual General Meeting. According to the scrutinizer's report, the resolution for his appointment received overwhelming support from shareholders. Out of the total votes cast, 99.77% were in favor of the appointment, with only 0.23% dissenting.

Company Secretary's Confirmation

Neha Aggarwal, Company Secretary and Compliance Officer of MK Proteins Limited, has officially communicated this appointment to the stock exchanges, ensuring compliance with regulatory disclosure requirements.

The addition of Mr. Deepak Khetarpal to the board of MK Proteins Limited is expected to bring valuable financial and strategic insights to the company's governance structure, potentially contributing to its future growth and performance.